"10.1371_journal.pone.0110857","plos one","2014-11-12T00:00:00Z","Benjamin Maasoumy; Bela Hunyady; Vincenza Calvaruso; Mihály Makara; Johannes Vermehren; Attila Haragh; Simone Susser; Birgit Bremer; Gavin Cloherty; Michael P Manns; Antonio Craxì; Heiner Wedemeyer; Christoph Sarrazin","Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hanover, Germany; Somogy County Kaposi Mor Teaching Hospital, Kaposvar, Hungary; University of Pecs, Pecs, Hungary; Section of Gastroenterology, Di.Bi.M.I.S., University of Palermo, Palermo, Italy; Outpatient Clinic, Saint Laszlo Hospital, Budapest, Hungary; Department of Medicine 1, JW Goethe-University Hospital, Frankfurt am Main, Germany; Abbott Molecular, Des Plaines, Illinois, United States of America","Conceived and designed the experiments: BM BH MM MPM AC HW CS. Performed the experiments: BM BH VC JV AH SS BB GC. Analyzed the data: BM HW CS. Contributed reagents/materials/analysis tools: BM BH VC MM AH GC MPM AC HW CS. Wrote the paper: BM BH VC JV MM AH SS BB GC MPM AC HW CS.","BM received speaker and consulting fees from Abbott Molecular, Roche, MSD/Merck, Janssen-Cilaq. BH Received speaker and/or advisory services fees from Roche, MSD, AbbVie, Janssen Cilag, Bristol-Myers Squibb, Gilead and Boehringer Ingelheim. VC has nothing to disclose. MM received research grants from Abbvie, BMS, Gilead, Janssen, MSD, Novartis, Roche and consulting fees from Abbvie, BMS, Gilead, Janssen, MSD. JV has nothing to disclose. AH has nothing to disclose. SS has nothing to disclose. BB has nothing to disclose. GC is an employee of Abbott molecular. MPM received consulting fees from Roche, BMS, Gilead, Boehringer Ingelheim, Novartis Tibotec, Vertex, GSK, Merck/MSD, grant/research support from Roche, BMS, Gilead, Boehringer Ingelheim, Novartis, Merck/MSD and lecture fees from Merck/MSD, Roche, BMS, Gilead. AC received research support from Abbvie, Bayer, Gilead, Merck, Roche and consulting fees from Abbvie, Achillon, Boehringer Ingelheim, BMS, Gilead, GSK, Janssen, Merck, Novartis, Roche. HW received research support from Roche, BMS, Novartis, Abbott and speacking and/or consulting fees from Abbvie, Abbott, Achillon, BMS, Boehringer, Gilead, GSK, Merck, Novartis, Roche, Siemens, Transgene. CS received research support from Abbott and Roche and consulting/speaker fees from Abbott and Roche. The co-author HW is a PLOS ONE Editorial Board member and this does not alter the authors adherence to PLOS ONE Editorial policies and criteria.","2014","11","Benjamin Maasoumy","BM",13,TRUE,7,8,3,13,TRUE,TRUE,FALSE,0,NA,FALSE
